You can cut wound care costs by 20% without switching brands—just by matching the dressing to the wound
If I had a dollar for every time I saw a hospital buying Mepilex Border for a simple, non-exuding surgical wound... I wouldn't need to manage a procurement budget. Here's the blunt truth: the single biggest waste in wound care isn't the price of the dressing; it's the mismatch between the product and the clinical need.
At my facility (a 300-bed regional hospital), I manage the annual wound care consumables budget—roughly $240,000 as of January 2025. Over the past 4 years, I've tracked every order and every line item. And I started noticing a pattern: we were using high-end foam dressings where a basic pad would do. The culprit? Habit. And the desire for 'the best' in every situation.
Let me rephrase that: we were using a Ferrari to pick up groceries. It works, but it's expensive overkill.
How I realized we had a problem
In early 2024, I did a deep dive into our Q3 '23 spending. I pulled up 14 months of invoices for our surgical unit. What I found surprised me: 58% of the Mepilex Border orders were for post-op incisions that closed within 48 hours. These incisions were clean, dry, and healing normally. They didn't need a silicone foam dressing designed for heavy exudate and fragile skin. They needed a simple absorbent pad and tape. (Should mention: this wasn't a clinical error—those dressings are perfectly safe. But it was an economic one.)
The conventional wisdom is that premium dressings are always better. My experience with two years of line-by-line analysis suggests otherwise: the 'best' product is the one that fits the wound's specific exudate and skin condition requirements. Not the one with the most impressive clinical study.
What I did about it—and what happened next
I didn't single-handedly rip up the generic preference list. That would have been a disaster. Instead, I did two things:
- I asked our wound care nurse team to create a simple flow chart: "Is the wound dry and healing? Use a basic pad. Is it exuding or at risk? Use Mepilex Border." That sounds obvious, but we didn't have it documented.
- I updated our procurement policy: Our purchasing system now flags any order exceeding a certain unit cost for a wound category unless a specific clinical reason is noted. We've built this logic into our inventory management software (based on NHS Supply Chain data, Q1 2024).
The result? In Q2 2024, when we switched a portion of our post-op orders from Mepilex Border to a standard adhesive dressing, we saved $4,200 that quarter alone. That's 17% of our overall wound care budget for that unit. And the clinical outcomes didn't change—infection rates stayed consistent. (Oh, and we kept Mepilex Border for high-risk patients like diabetics or those with fragile skin. That's non-negotiable.)
The real cost isn't just the unit price—it's the TCO
Everything I'd read about healthcare procurement said 'negotiate lower prices with vendors.' In practice, for wound care, that's a small piece of the puzzle. The real driver of total cost of ownership (TCO) is waste—using the wrong product for the wrong patient. And that waste is hidden in inventory, disposal, and the opportunity cost of not having the right dressing available for the right patient when needed.
I should add that I'm not anti-premium. Molnlycke's Safetac technology is genuinely a game-changer for patients with fragile skin or high pain sensitivity. I've seen it reduce dressing change trauma. I'm not saying cut corners on safety. I'm saying don't buy a $6 dressing when a $1 dressing will do the same clinical job for that specific patient. That's the definition of cost-effective care.
Where this approach breaks down
This won't work everywhere. First, it requires good clinical documentation. If your nurses don't accurately record wound exudate levels, you can't automate or optimize. I should know—we tried in 2023 and it failed miserably because the data was terrible. Second, it's hard to implement in a system with multiple decision-makers. We had to get buy-in from the head of nursing and the surgical team. Third, if your institution owns a shared formulary with groups that don't trust guidelines, they'll just order what they've always used. (Put another way: change management is harder than product selection.)
Bottom line: cost optimization in wound care is 80% product-wound matching and 20% vendor negotiation. Focus on the match first, and you'll find your budget goes much further—even within a single-brand portfolio like Molnlycke. Just make sure you verify current pricing at your supplier's official website (as of January 2025), because rates change.
